# Utility of Sodium Lactate Infusion During Septic Shock

> **NCT03528213** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 59 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Sodium Lactate light dose
- **DRUG:** Sodium Lactate high dose
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03528213
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-04
- **Primary completion:** 2023-02-21
- **Final completion:** 2023-02-21
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03528213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03528213, "Utility of Sodium Lactate Infusion During Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03528213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*